Heart Attack
Heart attack is defined as a medical condition when there is an imbalance between the demand and supply of blood flow to the heart.
State of the Art Cath Lab for Precision Heart Care
Heart Services at Heart & Vascular Superspecialist Hospitals covers the full spectrum of cardiac medicine currently available globally. It involves diagnosing and treating various heart-related disorders with both medicines and invasive procedures. All forms of disorders, from congenital heart conditions like septal defects to acquired heart conditions like heart attacks and valvular heart disorders, come under its paradigm.
The hospital boasts of latest hardware infrastructure which enables the heart specialist doctors to perform most complex procedures with ease. We take pride in having the dedicated cardiac ICU at our facility which is effectively managed to cater to any emergency and post procedure care.
Our dedicated team of doctors are here to provide you with world-class care. With extensive experience and specialized expertise, our consultants are committed to delivering personalized and comprehensive treatment plans.
Structural & Interventional Cardiologist
MD, DM (Cardiology), FSCAI
Location - Dadar
View profile
Structural & Interventional Cardiologist
MD, DM, DNB (Cardiology), FSCAI
Location - Ghatkopar
View profile
Cardiologist & Structural Heart Specialist
MBBS, DNB (Medicine), DrNB (Cardiology)
Location - Borivali
View profile
Cardiovascular, Thoracic Surgeon & Heart Transplant Specialist
MCh CVTS, M.S., MBBS, FMAS
Location - Ghatkopar
View profileHarnessing the latest advancements in medical technology, our heart department offers state-of-the-art diagnostic and treatment options to ensure precise, effective, and minimally invasive care for all heart conditions.
Rare Condition: A Cameral Fistula is an abnormal connection between aorta which is the great artery and a heart chamber (atrium or ventricle).
History
A 6 years old girl experienced breathlessness, chest murmur, and irregular heartbeat.
After consulting multiple hospitals in Mumbai, her family sought a safe solution.
They chose HVS Hospital for its proven expertise in handling complex cardiovascular cases.
Aortogram showing the fistula.
Understanding the pathway of the fistula.
Same Fistula seen in another view.
Crossing the Wire Through the Fistula and Snaring from the Right Vein.
A closure device was first placed at the aortic end of the fistula to control blood flow.
Subsequently, a second device was deployed at the RA end of the fistula to ensure complete occlusion.
Following the deployment, an aortogram confirmed the successful closure of the fistula. The coronary arteries were intact & blood flow was normalized, ensuring the safety and stability of the procedure.
Our expert team handles such complex cases with success at HVS Hospitals. A happy 6-year-old child was discharged on Children’s Day after undergoing a successful Closure of Aorto-Cameral Fistula procedure.
A 3 years baby was admitted with history of breathlessness for 1 year with no weight gain. She was a pre-term baby (7 months LSCS) and was diagnosed to have Congenital Heart Disease (Acynotic) with moderate to severe pulmonary stenosis. After detailed evaluation she underwent Balloon Pulmonary Valvuloplasty.
The pulmonary valvuloplasty was performed with 14 X 40 mm balloon, which was inflated (twice) at nominal pressure at the valve plane level, with the formation and disappearance of the hourglass image.
Post-Pulmonary valvuloplasty pressures were: RA = 9, Pulmonary gradient: 20 mm of Hg (Pre Procedure gradient — 50 mm of Hg), RV = 60/4 (Pre Procedure 48/4) with no significant gradient post procedure . Therefore, the procedure was considered very successful.
A 67 years old male patient with a history of dyspnoea of exertion since 1 month which worsened since 15 days. He was diagnosed with severe Aortic Valve Stenosis.
Vitals Stable
CVS – EFM Systolic Murmur
He underwent TAVI (Trancatheter Aortic Valve Implantation) under local Anaesthisia + Sedation by Dr. Ankur Phatarpekar and his team through right femorial artery.
Post procedure was shifted to ICU with stable Haemodynamic for observation.
Post procedure ECG sinus rhythm no ST-T changes.
After 24hrs left femorial sheaths were removed.
He was mobilised out of the bed.
Beta Blockers with held in view of Borderline Bradycardia.
Post Procedure Echo Screening.
2D-Echo – Gross Concentric LVH. All chambers normal size. Mild and distal septum mildly hypokinetic. Heavily calcified Aortic valve with reduced opening with peak by mean gradient of 86/53 mm of Hg suggestive of Severe AS with Grade ¼ AR. Grade ¼ MR, Grade ¼ AR. No evidence of PR/TR. No significant gradient across LVOT/RVOT. Normal LVEF – 61%
2D-ECHO- Normal LV systolic function. k/c/o degenerative Severe AS , s/p TAVI with normally functioning of Aortic valve. Mild Concentric LVH. All chambers normal size.
Bioprosthetic Aortic valve in situ, opening well. No e/o paravalvular leak.
Grade I MR. No evidence of AR/PR/TR. Peak by mean gradient across Aortic valve is 28/16 mm of Hg. AVA by continuity is 1.43 sq.cm.
LVEF 65%.
Right femorial and left femorial artery venous punctured.
Left femorial side 6-F sheath introduced in both venous and artery.
Right common femorial artery 10-F sheath introduced.
23 size balloon used for commissurotomy and inflated for 3 seconds.
Ventricle with pacing at 180 beats/min gradiant aortic valve – nil.
Following commissurotomy 23 size MyVal pericardial, bioprothes crimpel introduced and implanted across aortic valve with ventricular pacing of 180 beats/min.
No para valvular leak.
Good result.
Right femorial cannulation closed with proglide.
2 proglide used.
Good haemostasis.
Patient tolerated procedure well.
An 80-year-old male patient presented to HVS Superspeciality Hospital with acute severe mitral regurgitation (MR) and complex coronary artery disease (CAD). The case was high-risk, involving multiple critical cardiac pathologies:
The clinical challenge lay in managing both the valvular and ischemic burden, especially considering the patient's advanced age and comorbid status.
Treatment Plan:
1. Percutaneous Coronary Intervention (PCI) to LCX and OM — aimed at relieving the ischemic burden.
2. Staged Mitral Valve Repair using MitraClip therapy (Indian brand: Meril’s MyClip) — a revolutionary transcatheter edge-to-edge repair (TEER) system designed to reduce MR without the need for open-heart surgery.
Procedure 1: Angioplasty of LCX and OM
The first stage involved successful angioplasty and stenting of the LCX and OM arteries. The LAD was found to be non-viable, and hence not revascularized. The intervention restored perfusion to large myocardial territories and stabilized the patient for the second stage.
Outcome: Procedure was uneventful, and the patient showed significant symptomatic relief from angina and dyspnea.
Procedure 2: Mitral Valve Repair with MyClip
After cardiac stabilization, a transcatheter mitral valve repair was performed using the MyClip system by Meril Life Sciences — a cutting-edge Indian technology allowing precise, edge-to-edge leaflet approximation.
Result: Post-clip deployment, there was only trivial residual MR, and the patient showed dramatic clinical improvement.
Team of Experts
This complex, staged hybrid intervention was made possible by the synergy of an expert multi-disciplinary team:
Interventional Cardiologists
Interventional Imaging Specialists
Conclusion
This case highlights the power of team-based, staged, and minimally invasive therapy for managing complex cardiac disease in elderly patients. By combining revascularization with transcatheter mitral repair, the heart team at Heart & Vascular Superspeciality Hospitals was able to provide a new lease of life to a high-risk, elderly patient — without open-heart surgery.
